Open Label Ustekinumab for the Treatment of Anti-TNFα Refractory Moderate-to-Severe Crohnʼs Disease

Autor:	Stephen Rotman, Ellen Scherl, Brian P. Bosworth, Melissa H. Rosen
Rok vydání:	2011
Předmět:	Moderate to severe medicine.medical_specialty Hepatology business.industry Gastroenterology Disease Refractory Internal medicine Ustekinumab Medicine Tumor necrosis factor alpha Open label business medicine.drug
Zdroj:	American Journal of Gastroenterology. 106:S486-S487
ISSN:	0002-9270
DOI:	10.14309/00000434-201110002-01277
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f52cd63e3e95c68bfd3cdad279ca10c3 https://doi.org/10.14309/00000434-201110002-01277 Zobrazit plný text záznamu